Bertagnolli NIH Nomination Advances, But Sanders Will Remain Thorn In Side Of Biden’s Health Agenda

After increasing his drug pricing-related complaints, the HELP committee chair opposed Bertagnolli becoming NIH director, but a bipartisan group of senators voted 15-6 in favor of moving her nomination to the full Senate.

More from Pricing Debate

More from Market Access